AD patients exhibited enhanced extracellular β-amyloid protein levels, Aβ deposition, abnormal phosphorylation of tau protein, neuronal loss, neurodystrophy, and synaptic formation. The gene discussed is MAPT; the disease is Alzheimer disease.